InvestorsHub Logo

powerwalker

04/14/23 7:05 AM

#410880 RE: BAR123 #410879

Great find, Blar. Critics will like this as it is now easier for Anavex to get rid of TGD as he will reports to someone, i.e., the Chairperson of the Board.

To me, it is a sign that the Board knows the Company's growth is imminent and it needs a governance and management structure that spreads the responsibility, decision making and knowledge. Additionally, the Chairperson will likely participate in the cc's. No more, one man shows.

IMO, this is positive news to all who are focused on Anavex.

BIOChecker4

04/14/23 9:26 AM

#410900 RE: BAR123 #410879

A biopharma partner would not be concerned with having an independent chairman of the board. Partners deal with operating management.

This is about governance and finally dealing with the fact that Missling is now more of a liability than an asset. The guy has had free rein to do as he pleases, to the detriment of shareholders. If Anavex is to have a chance at real success, Missling must be replaced.

Kb1123

04/14/23 11:15 AM

#410918 RE: BAR123 #410879

Or maybe it’s just dividing the power. Missling always had way too much. Question becomes who will be the new Chairman of the Board?